Medpace Holdings, Inc. MEDP
656.92 USD -7.85 (-1.18%)
Nov 12, 2026, 12:52 PM EST
648.35 Day range 661.02
373.00 52-week range 693.97
- YTD
- +16.96%
- 1 year
- +9.93%
News
zacks.com 3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP) Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
defenseworld.net Medpace Holdings, Inc. $MEDP Stock Sold by CenterBook Partners LP CenterBook Partners LP lessened its stake in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) by 31.1% in the undefined quarter, according to the company in its most recent 13F filing with the SEC.…
seekingalpha.com Madison Mid Cap Fund Q3 2026 Portfolio Activity The Madison Mid Cap Fund (Class I) returned -2.09% in the third quarter, compared to the Russell Midcap Index return of -3.00%. The top five contributors for the quarter were Gartner, Medpace…
benzinga.com BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $670 BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and raises the price target from $600 to $670.
benzinga.com UBS Maintains Neutral on Medpace Holdings, Raises Price Target to $700 UBS analyst Kevin Caliendo maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $673 to $700.
benzinga.com Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $633 Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $609 to $633.
benzinga.com Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675 Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $625 to $675.- benzinga.com TD Cowen Maintains Hold on Medpace Holdings, Raises Price Target to $673 TD Cowen analyst Charles Rhyee maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $492 to $673.
benzinga.com Medpace Hldgs Q3 2026 Earnings Call Transcript Medpace Hldgs (NASDAQ:MEDP) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…- benzinga.com Medpace Holdings Raises FY2026 GAAP EPS Guidance from $17.25-$17.95 to $17.97-$18.32 vs $17.60 Est; Narrows FY2026 Sales Guidance from $2.805B-$2.885B to $2.835B-$2.855B vs $2.851B Est Medpace Holdings (NASDAQ:MEDP) raises FY2026 GAAP EPS guidance from $17.25-$17.95 to $17.97-$18.32 vs $17.60 analyst estimate. Narrows FY2026 sales outlook from $2.805 billion-$2.885 billion to…
benzinga.com Medpace Hldgs Q3 EPS $4.84 Beats $4.44 Estimate, Sales $716.000M Beat $715.975M Estimate Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $4.84 per share which beat the analyst consensus estimate of $4.44 by 9.01 percent. This is a 25.39 percent increase over earnings of $3.86…
benzinga.com SpaceX Jumps 10%, Nasdaq 100 Rises as AI Trade Returns: Stock Market Today SpaceX's blowout third quarter and Super Micro's guidance hike revive the AI trade, lifting the Nasdaq 100 as Netflix and AT&T slide on results.
benzinga.com Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International,…
benzinga.com Earnings Volatility Watch: Bloom Energy and Other 11 Stocks Are Priced For Double-Digit Swings Options price moves above 10% in 12 stocks next week, from TTM Technologies at 20.73% to Stifel Financial at 10.03%. The reports land after a chip and memory selloff that also hit CoreWeave- benzinga.com Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $700 Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $665 to $700.
- benzinga.com Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $625 Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $600 to $625.
benzinga.com Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 10 Years Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 21.36% on an annualized basis producing an average annual return of 35.2%. Currently, Medpace Holdings has a…- benzinga.com Here's How Much $100 Invested In Medpace Holdings 10 Years Ago Would Be Worth Today Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 21.9% on an annualized basis producing an average annual return of 35.51%. Currently, Medpace Holdings has a…
- benzinga.com UBS Upgrades Medpace Holdings to Neutral, Raises Price Target to $673 UBS analyst Kevin Caliendo upgrades Medpace Holdings (NASDAQ:MEDP) from Sell to Neutral and raises the price target from $405 to $673.
- benzinga.com Here’s How Much You Would Have Made Owning Medpace Holdings Stock In The Last 5 Years Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 15.31% on an annualized basis producing an average annual return of 26.82%. Currently, Medpace Holdings has a…
benzinga.com If You Invested $1000 In Medpace Holdings Stock 10 Years Ago, You Would Have This Much Today Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 10 years by 22.9% on an annualized basis producing an average annual return of 36.28%. Currently, Medpace Holdings has a…
benzinga.com If You Invested $100 In Medpace Holdings Stock 5 Years Ago, You Would Have This Much Today Medpace Holdings (NASDAQ:MEDP) has outperformed the market over the past 5 years by 14.56% on an annualized basis producing an average annual return of 26.38%. Currently, Medpace Holdings has a…
benzinga.com Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $665 Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $586 to $665.- benzinga.com BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $600 BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and raises the price target from $400 to $600.
- benzinga.com Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $609 Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $462 to $609.
benzinga.com RBC Capital Maintains Outperform on Medpace Holdings, Raises Price Target to $692 RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $484 to $692.
benzinga.com Baird Maintains Neutral on Medpace Holdings, Raises Price Target to $624 Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $547 to $624.
benzinga.com Medpace Soars After Q2 Beat, Strong Backlog Fuels Higher 2026 Outlook Medpace says second-quarter earnings and revenue beat estimates, backed by stronger bookings, backlog growth and higher 2026 guidance.
benzinga.com Brent Tops $100, Alphabet, Tesla Sink Nasdaq 100: Stock Market Today Stocks slide Thursday as Brent crude breaks $100 and the 10-year yield hits an 18-month high, while Alphabet and Tesla earnings revive AI-spending doubts.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers NovoCure (NASDAQ:NVCR) shares moved upwards by 27.7% to $19.88 during Thursday's regular session. The market value of their outstanding shares is at $1.8 billion. The company's, Q2 earnings…- benzinga.com Full Transcript: Medpace Hldgs Q2 2026 Earnings Call On Thursday, Medpace Hldgs (NASDAQ:MEDP) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga…
benzinga.com Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday U.S. stocks were down as Dow Jones fell 450 points on Thursday. Lockheed Martin (LMT) shares rose 11.4% on better-than-expected results. Other big gainers were NVE Corp (NVEC), Gibo Holdings Ltd…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Niki BioSolutions (NASDAQ:NIKI) stock moved upwards by 44.7% to $13.01 during Thursday's pre-market session. The company's market cap stands at $73.2 million. Zhengye Biotechnology…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares moved upwards by 24.0% to $1.71 during Wednesday's after-market session. The market value of their outstanding shares is at $135.0 million. Medpace…- benzinga.com Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755B-$2.855B to $2.805B-$2.885B vs $2.778B Est Medpace Holdings (NASDAQ:MEDP) raises FY2026 GAAP EPS guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 analyst estimate. Raises FY2026 sales outlook from $2.755 billion-$2.855 billion to $2.805…
benzinga.com Medpace Hldgs Q2 EPS $4.25 Beats $3.97 Estimate, Sales $707.331M Beat $687.647M Estimate Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $4.25 per share which beat the analyst consensus estimate of $3.97 by 7.05 percent. This is a 37.1 percent increase over earnings of $3.10…
benzinga.com Earnings Scheduled For July 22, 2026 Companies Reporting Before The Bell • Northern Trust (NASDAQ:NTRS) is expected to report quarterly earnings at $3.45 per share on revenue of $2.35 billion. • Old National Bancorp (NASDAQ:ONB) is…
benzinga.com Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $586 Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $495 to $586.
benzinga.com This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday Top Wall Street analysts changed outlook on top names, see all changes on analyst ratings page. HCA downgraded and price target slashed.- benzinga.com Baird Downgrades Medpace Holdings to Neutral, Raises Price Target to $547 Baird analyst Eric Coldwell downgrades Medpace Holdings (NASDAQ:MEDP) from Outperform to Neutral and raises the price target from $477 to $547.
benzinga.com This Truist Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday Top Wall Street analysts changed outlook on some top names. Check all changes on analyst ratings page. See how others view TFC stock before buying.- benzinga.com Jefferies Downgrades Medpace Holdings to Hold, Raises Price Target to $515 Jefferies analyst David Windley downgrades Medpace Holdings (NASDAQ:MEDP) from Buy to Hold and raises the price target from $490 to $515.
benzinga.com Congressman Looking For Dividends? Taylor Ditches 2 Magnificent Seven Stocks For Blue Chips A congressman ditches some Magnificent Seven stocks to buy some blue-chip, high dividend yield stocks.
benzinga.com Tractor Supply, Lululemon, and Northrop Grumman Are Among Top 10 Large-Cap Losers Last Week (April 20-April 24): Are The Others In Your Portfolio? Large-cap stocks slid sharply last week, pressured by earnings misses, weak guidance and analyst downgrades across sectors.- benzinga.com Barclays Maintains Equal-Weight on Medpace Holdings, Lowers Price Target to $450 Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and lowers the price target from $500 to $450.
- benzinga.com BMO Capital Maintains Market Perform on Medpace Holdings, Lowers Price Target to $400 BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and lowers the price target from $460 to $400.
- benzinga.com RBC Capital Maintains Outperform on Medpace Holdings, Lowers Price Target to $484 RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $522 to $484.
- benzinga.com Baird Maintains Outperform on Medpace Holdings, Lowers Price Target to $477 Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $565 to $477.
benzinga.com Medpace Flags Rising Cancellations, Near-Term Growth Uncertain Medpace stock drops despite Q1 beat as cancellations rise, bookings miss weighs on outlook and management flags near-term uncertainty.- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session